Tectonic Therapeutic (TECX) Other Non Operating Income (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Other Non Operating Income of -$113000.0 for Q1 2026, down 253.12% year-over-year from $73795.9 in Q1 2025, and down 102.67% quarter-over-quarter from $4.2 million in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Other Non Operating Income (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Other Non Operating Income for 9 consecutive years, with -$113000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 253.12% year-over-year to -$113000.0; the TTM figure through Mar 2026 stood at $4.0 million (up 3010.79% YoY), while the FY2025 annual figure was $4.1 million, up 907.63% from the prior year.
- Other Non Operating Income eased to -$113000.0 in Q1 2026 per TECX's latest filing, from $4.2 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $4.2 million in Q4 2025 and bottomed at -$403000.0 in Q1 2024.
- Historically, Other Non Operating Income has averaged $236312.5 across 5 years, with a median of -$19500.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Non Operating Income tumbled 2786.67% — and 2025, when it soared 4561.05%.
- Tectonic Therapeutic's Other Non Operating Income stood at -$95000.0 in 2022, then jumped by 527.37% to $406000.0 in 2023, then slumped by 123.4% to -$95000.0 in 2024, then jumped by 4561.05% to $4.2 million in 2025, then slumped by 102.67% to -$113000.0 in 2026.
- Business Quant data shows TECX's Other Non Operating Income at -$113000.0 in Q1 2026, $4.2 million in Q4 2025, and -$31000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 583.14 Mn | 583.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5,000.00 |
| Mar 31, 2026 | -113,000.00 |
| Dec 31, 2025 | 4.24 Mn |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | -48,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -403,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 195,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Sep 30, 2022 | -95,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | -45,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Sep 30, 2020 | -74,000.00 |